Some large-scale epidemiological studies have reported that (a) patients with Hp-I exhibit an increased risk for the subsequent development of EAC [2], and MCs may contribute to this tumor [78], and (b) there is the absence on an increased risk of EAC after Hp eradication, signifying that eradication is safe from a tumor perspective [79]. This evidence concerns the gene HP and neoplasm.